Gene of the month: SDH

J Clin Pathol. 2018 Feb;71(2):95-97. doi: 10.1136/jclinpath-2017-204677. Epub 2017 Oct 25.

Abstract

Succinate dehydrogenase (SDH) is a heterotetrameric nuclear encoded mitochondrial protein complex which plays a role in the citric acid cycle and the electron transfer chain. Germline mutations in SDHA are associated with Leigh syndrome. Mutations in SDHB, SDHC and SDHD are found in an increasing number of neoplasms, most notably paragangliomas and wild-type gastrointestinal stromal tumours. SDH deficiency in these tumours has important prognostic implications, and also provides a novel target for molecular therapy. In this article, we outline the structure and function of SDH and provide a summary of its role in various diseases.

Keywords: genetics; molecular pathology; neoplasms.

Publication types

  • Review

MeSH terms

  • Cardiomyopathy, Dilated / genetics
  • Electron Transport Complex II / deficiency
  • Electron Transport Complex II / genetics
  • Gastrointestinal Neoplasms / genetics
  • Gastrointestinal Stromal Tumors / genetics
  • Genetic Markers
  • Genetic Predisposition to Disease*
  • Germ-Line Mutation
  • Hamartoma Syndrome, Multiple / genetics
  • Humans
  • Leigh Disease / genetics
  • Membrane Proteins / deficiency
  • Membrane Proteins / genetics
  • Nervous System Neoplasms / genetics
  • Paraganglioma / genetics
  • Succinate Dehydrogenase / deficiency
  • Succinate Dehydrogenase / genetics*

Substances

  • Genetic Markers
  • Membrane Proteins
  • SDHC protein, human
  • SDHD protein, human
  • Electron Transport Complex II
  • SDHA protein, human
  • SDHB protein, human
  • Succinate Dehydrogenase